Drug Development Solutions

  1. Resin Offering High Productivity And Robust Processes 5/3/2023

    MabSelect™ VL affinity resin uses a protein L ligand with strong affinity for the variable region of a human antibody’s kappa light chain. The resin offers high productivity and robust processes for affinity capture of bispecific antibodies and antibody fragments containing the kappa light chain and offers a good capture alternative for antibody variants that does not bind to protein A.

  2. Testing Solutions For Antibody-Based Products 4/22/2024

    Explore our suite of analytical testing services for antibody-based drugs, encompassing feasibility studies, method development, validation, routine testing, and stability assessments, all aligned with rigorous regulatory standards.

  3. Accelerate Molecules Through Development With Translational Pharmaceutics® 3/17/2025

    By leveraging real-time data and operational efficiency, we accelerate timelines — manufacturing and releasing drug products in under seven days and reducing development cycles by up to 12 months.

  4. ADCs: Analytical Considerations For QC Release, Stability Testing, Characterization, Comparability 4/28/2025

    Develop a robust analytical strategy to ensure the quality and consistency of your antibody-drug conjugate by evaluating each component and navigating multi-site manufacturing complexities.

  5. Analytics-Driven AAV Development And Manufacturing 3/26/2025

    Gain a comprehensive understanding of the biochemical composition of each vector batch while minimizing product consumption, ensuring efficiency and precision in analysis.

  6. Comprehensive Manufacturing Solutions Backed By Global Expertise 8/4/2025

    Gain insight into a CDMO with global, end-to-end mammalian manufacturing solutions, proven expertise, flexible capacity, and a strong track record in regulatory compliance that can support your company's needs.

  7. Improving Cell Line Development Efficiency With AbZelect™ 11/19/2024

    By streamlining timelines and reducing risks in downstream processes, Abzena’s solutions enhance efficiency, helping developers navigate the IND pathway more effectively and meet critical milestones with confidence.

  8. Antibody Drug Conjugates: Link Your Antibody To Its Fullest Potential

    Learn how our parallel development service works seamlessly with our existing antibody capabilities, helping to accelerate your ADC program and reach market faster.

  9. Cell Culture Media For Viral Vector Applications 11/3/2025

    Explore media solutions for viral vector production that support HEK293 and insect cells, with custom development, analytical testing, and scalable preparation tools to optimize performance.

  10. Oligonucleotide Discovery And Development 8/7/2025

    Observe how comprehensive R&D support advances therapeutic oligonucleotides from discovery through commercialization with tailored formulation development services across multiple modalities and delivery platforms.